TNFSF10 and sarcoma: LUV-TRAIL combined with flavopiridol (FVP) reduced human sarcoma cells’ long-term clonogenic survival and triggered apoptosis by downregulating FLIP and XIAP and activating caspases, compared to soluble TRAIL (sTRAIL) alone[112].